Anti-Tumor Nucleic Acid Drug Discovery Platform
Successful application of nucleic acid therapeutics faces many challenges, including delivery efficiency and off-target effects. To address these challenges, WuXi AppTec offers a full suite of nucleic acid-related services, including target validation, in vitro screening and cell-based functional assays, drug exposure analysis, biodistribution evaluation, PK/PD/efficacy testing, and safety assessment. Leverage our comprehensive platform to accelerate your research!
Check out our comprehensive platform of oligonucleotide services by clicking HERE

Anti-tumor nucleic acid drug discovery platform
Related Content
Varicella-zoster virus (VZV) is a highly contagious alpha-herpesvirus that infects more than 90% of people worldwide. The primary infection with...
VIEW RESOURCECellular senescence plays a crucial role in aging and age-related diseases, making its study essential for the development of new...
VIEW RESOURCE
